Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 611

1.

Effects of early life adversity on immune function and cognitive performance: results from the ALSPAC cohort.

Holland JF, Khandaker GM, Dauvermann MR, Morris D, Zammit S, Donohoe G.

Soc Psychiatry Psychiatr Epidemiol. 2020 Jan 2. doi: 10.1007/s00127-019-01813-8. [Epub ahead of print]

PMID:
31897578
2.

The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.

Maharaj AD, Holland JF, Scarborough RO, Evans SM, Ioannou LJ, Brown W, Croagh DG, Pilgrim CHC, Kench JG, Lipton LR, Leong T, McNeil JJ, Nikfarjam M, Aly A, Burton PR, Cashin PA, Chu J, Duong CP, Evans P, Goldstein D, Haydon A, Hii MW, Knowles BPF, Merrett ND, Michael M, Neale RE, Philip J, Porter IWT, Smith M, Spillane J, Tagkalidis PP, Zalcberg JR.

BMJ Open. 2019 Sep 30;9(9):e031434. doi: 10.1136/bmjopen-2019-031434.

3.

Beyond C4: Analysis of the complement gene pathway shows enrichment for IQ in patients with psychotic disorders and healthy controls.

Holland JF, Cosgrove D, Whitton L, Harold D, Corvin A, Gill M, Mothersill DO, Morris DW, Donohoe G.

Genes Brain Behav. 2019 Nov;18(8):e12602. doi: 10.1111/gbb.12602. Epub 2019 Aug 30.

PMID:
31385409
4.

A phase 1/2 study of rigosertib in patients with myelodysplastic syndromes (MDS) and MDS progressed to acute myeloid leukemia.

Navada SC, Fruchtman SM, Odchimar-Reissig R, Demakos EP, Petrone ME, Zbyszewski PS, Holland JF, Silverman LR.

Leuk Res. 2018 Jan;64:10-16. doi: 10.1016/j.leukres.2017.11.006. Epub 2017 Nov 11.

PMID:
29144985
5.

Erratum to: Mouse mammary tumor-like virus (MMTV) is present in human breast tissue before development of virally associated breast cancer.

Nartey T, Mazzanti CM, Melana S, Glenn WK, Bevilacqua G, Holland JF, Whitaker NJ, Lawson JS, Pogo BGT.

Infect Agent Cancer. 2017 Mar 15;12:16. doi: 10.1186/s13027-017-0126-9. eCollection 2017.

6.

Mouse mammary tumor-like virus (MMTV) is present in human breast tissue before development of virally associated breast cancer.

Nartey T, Mazzanti CM, Melana S, Glenn WK, Bevilacqua G, Holland JF, Whitaker NJ, Lawson JS, Pogo BG.

Infect Agent Cancer. 2017 Jan 4;12:1. doi: 10.1186/s13027-016-0113-6. eCollection 2017. Erratum in: Infect Agent Cancer. 2017 Mar 15;12 :16.

7.

Downstaging cancer in rural Africa.

Ngoma T, Mandeli J, Holland JF.

Int J Cancer. 2015 Jun 15;136(12):2875-9. doi: 10.1002/ijc.29348. Epub 2014 Dec 3.

8.

Human Mammary Tumor Virus (HMTV) sequences in human milk.

Nartey T, Moran H, Marin T, Arcaro KF, Anderton DL, Etkind P, Holland JF, Melana SM, Pogo BG.

Infect Agent Cancer. 2014 Jun 17;9:20. doi: 10.1186/1750-9378-9-20. eCollection 2014.

9.

Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy.

Silverman LR, Greenberg P, Raza A, Olnes MJ, Holland JF, Reddy P, Maniar M, Wilhelm F.

Hematol Oncol. 2015 Jun;33(2):57-66. doi: 10.1002/hon.2137. Epub 2014 Apr 29.

10.

Longer-term functional outcomes and everyday listening performance for young children through to young adults using bilateral implants.

Galvin KL, Holland JF, Hughes KC.

Ear Hear. 2014 Mar-Apr;35(2):171-82. doi: 10.1097/01.aud.0000436923.96492.3a.

PMID:
24556966
11.

Emil Frei III, 1924-2013.

Holland JF, Freireich EJ.

J Clin Oncol. 2013 Oct 20;31(30):3727-30. doi: 10.1200/JCO.2013.51.8126. Epub 2013 Sep 9. No abstract available.

PMID:
24019548
12.

Human mammary tumor virus (HMTV) in endometrial carcinoma.

Deligdisch L, Marin T, Lee AT, Etkind P, Holland JF, Melana S, Pogo BG.

Int J Gynecol Cancer. 2013 Oct;23(8):1423-8. doi: 10.1097/IGC.0b013e3182980fc5.

PMID:
23873177
13.

Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer.

Ohnuma T, Lehrer D, Ren C, Cho SY, Maniar M, Silverman L, Sung M, Gretz HF 3rd, Benisovich V, Navada S, Akahoho E, Wilck E, Taft DR, Roboz J, Wilhelm F, Holland JF.

Am J Cancer Res. 2013 Jun 20;3(3):323-38. Print 2013.

14.

The African Organization for Research and Training in Cancer: historical perspective.

Mohammed SI, Williams CK, Ndom P, Holland JF.

Curr Oncol. 2012 Oct;19(5):272-6. doi: 10.3747/co.19.1075.

15.

Morphological and molecular analysis of a breast cancer cluster at the ABC Studio in Toowong.

Waddell N, Stein SR, Wagner SA, Bennett I, Djougarian A, Melana S, Jaffer S, Holland JF, Pogo BG, Gonda TJ, Brown MA, Leo P, Saunders NA, McMillan NA, Cocciardi S, Vargas AC, Lakhani SR, Chenevix-Trench G, Newman B, Francis GD.

Pathology. 2012 Aug;44(5):469-72. doi: 10.1097/PAT.0b013e3283559e67. No abstract available.

PMID:
22744170
16.

Prevention of Doxorubicin cardiopathic changes by a benzyl styryl sulfone in mice.

Lu M, Merali S, Gordon R, Jiang J, Li Y, Mandeli J, Duan X, Fallon J, Holland JF.

Genes Cancer. 2011 Oct;2(10):985-92. doi: 10.1177/1947601911436199.

17.

Comment on the review by Joshi and Buehring.

Holland JF, Pogo BG.

Breast Cancer Res Treat. 2012 Nov;136(1):303-7. doi: 10.1007/s10549-012-2078-5. Epub 2012 May 6. No abstract available.

PMID:
22562175
18.

Planned simultaneous bilateral cochlear implant operations: how often do children receive only one implant?

Holland JF, Galvin KL, Briggs RJ.

Int J Pediatr Otorhinolaryngol. 2012 Mar;76(3):396-9. doi: 10.1016/j.ijporl.2011.12.019. Epub 2012 Jan 17.

PMID:
22261611
19.

Effect of ON 01910.Na, an anticancer mitotic inhibitor, on cell-cycle progression correlates with RanGAP1 hyperphosphorylation.

Oussenko IA, Holland JF, Reddy EP, Ohnuma T.

Cancer Res. 2011 Jul 15;71(14):4968-76. doi: 10.1158/0008-5472.CAN-10-1603. Epub 2011 Jun 6. Erratum in: Cancer Res. 2011 Sep 15;71(18):6086.

20.

PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins.

Platica M, Ionescu A, Ivan E, Holland JF, Mandeli J, Platica O.

Int J Oncol. 2011 Mar;38(3):777-85. doi: 10.3892/ijo.2011.900. Epub 2011 Jan 11.

PMID:
21225229
21.

Presence of MMTV-like env gene sequences in human breast cancer.

Pogo BG, Melana SM, Moran H, Holland JF.

Breast Cancer Res Treat. 2011 Jan;125(1):295-7. doi: 10.1007/s10549-010-1179-2. Epub 2010 Sep 26. No abstract available.

PMID:
20872240
22.

Human mammary tumor virus in inflammatory breast cancer.

Pogo BG, Holland JF, Levine PH.

Cancer. 2010 Jun 1;116(11 Suppl):2741-4. doi: 10.1002/cncr.25179.

23.

Discontinuous drug binding to proteins: binding of an antineoplastic benzyl styryl sulfone to albumin and enzymes in vitro and in phase I clinical trials.

Cho SY, Ohnuma T, Silverman LR, Holland JF, Roboz J.

Drug Metab Dispos. 2010 Sep;38(9):1480-5. doi: 10.1124/dmd.110.033001. Epub 2010 May 25.

PMID:
20501913
24.

Detection of human mammary tumor virus proteins in human breast cancer cells.

Melana SM, Nepomnaschy I, Hasa J, Djougarian A, Djougarian A, Holland JF, Pogo BG.

J Virol Methods. 2010 Jan;163(1):157-61. doi: 10.1016/j.jviromet.2009.09.015. Epub 2009 Sep 23.

PMID:
19781575
25.

Reovirus infection of cancer cells is not due to activated Ras pathway.

Song L, Ohnuma T, Gelman IH, Holland JF.

Cancer Gene Ther. 2009 Apr;16(4):382. doi: 10.1038/cgt.2008.84. Epub 2008 Oct 24. No abstract available.

PMID:
18949012
26.

Breaking the cure barrier 25 years later.

Holland JF.

J Clin Oncol. 2008 Apr 1;26(10):1575. doi: 10.1200/JCO.2007.13.8107. No abstract available.

PMID:
18375887
27.

Characterization of viral particles isolated from primary cultures of human breast cancer cells.

Melana SM, Nepomnaschy I, Sakalian M, Abbott A, Hasa J, Holland JF, Pogo BG.

Cancer Res. 2007 Sep 15;67(18):8960-5.

28.

Haemangioblastic transformation of myeloproliferative disease?

Strauchen JA, Cuttner J, Holland JF.

Br J Haematol. 2007 Sep;138(6):819-21. Epub 2007 Aug 2. No abstract available.

PMID:
17672881
29.

Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells.

Fernandez-Cobo M, Zammarchi F, Mandeli J, Holland JF, Pogo BG.

Oncol Rep. 2007 Apr;17(4):903-7.

PMID:
17342334
30.

Transcription profile of a human breast cancer cell line expressing MMTV-like sequences.

Fernandez-Cobo M, Melana SM, Holland JF, Pogo BG.

Infect Agent Cancer. 2006 Dec 15;1:7.

31.

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

Silverman LR, McKenzie DR, Peterson BL, Holland JF, Backstrom JT, Beach CL, Larson RA; Cancer and Leukemia Group B.

J Clin Oncol. 2006 Aug 20;24(24):3895-903.

PMID:
16921040
32.

A concise history of the cancer and leukemia group B.

Schilsky RL, McIntyre OR, Holland JF, Frei E 3rd.

Clin Cancer Res. 2006 Jun 1;12(11 Pt 2):3553s-5s. Review.

33.

Transcription profiles of non-immortalized breast cancer cell lines.

Fernandez-Cobo M, Holland JF, Pogo BG.

BMC Cancer. 2006 Apr 20;6:99.

34.

The Classic: amputation and adriamycin in primary osteosarcoma. 1974.

Cortes EP, Holland JF, Wang JJ, Sinks LF, Blom J, Senn H, Bank A, Glidewell O.

Clin Orthop Relat Res. 2005 Sep;438:5-8. No abstract available.

PMID:
16131861
35.

Contribution by Faedo et al. (Clin cancer res 2004;10:4417-4419).

Pogo B, Menard S, Holland JF.

Clin Cancer Res. 2005 Jan 1;11(1):406; author reply 406. No abstract available.

36.

Mouse mammary tumor virus-like viral infection and human breast cancer.

Holland JF, Pogo BG.

Clin Cancer Res. 2004 Sep 1;10(17):5647-9. Review. No abstract available.

37.
38.

Increasing evidence for a human breast carcinoma virus with geographic differences.

Levine PH, Pogo BG, Klouj A, Coronel S, Woodson K, Melana SM, Mourali N, Holland JF.

Cancer. 2004 Aug 15;101(4):721-6.

39.

A mouse mammary tumor virus-like long terminal repeat superantigen in human breast cancer.

Wang Y, Jiang JD, Xu D, Li Y, Qu C, Holland JF, Pogo BG.

Cancer Res. 2004 Jun 15;64(12):4105-11.

40.

A pituitary gene encodes a protein that produces differentiation of breast and prostate cancer cells.

Platica M, Ivan E, Holland JF, Ionescu A, Chen S, Mandeli J, Unger PD, Platica O.

Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1560-5. Epub 2004 Jan 26.

41.

Transformation of NIH 3T3 cells by enhanced PAR expression.

Platica M, Ivan E, Ionescu A, Holland JF, Mora G, Tindall DJ, Mandeli J, Unger PD, Platica O.

Biochem Biophys Res Commun. 2004 Feb 13;314(3):891-6.

PMID:
14741720
42.

High prevalence of MMTV-like env gene sequences in gestational breast cancer.

Wang Y, Melana SM, Baker B, Bleiweiss I, Fernandez-Cobo M, Mandeli JF, Holland JF, Pogo BG.

Med Oncol. 2003;20(3):233-6.

PMID:
14514972
43.

Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy.

Kornblith AB, Herndon JE 2nd, Weiss RB, Zhang C, Zuckerman EL, Rosenberg S, Mertz M, Payne D, Jane Massie M, Holland JF, Wingate P, Norton L, Holland JC.

Cancer. 2003 Aug 15;98(4):679-89.

44.

Putative protein markers in the sera of men with prostatic neoplasms.

Lehrer S, Roboz J, Ding H, Zhao S, Diamond EJ, Holland JF, Stone NN, Droller MJ, Stock RG.

BJU Int. 2003 Aug;92(3):223-5.

45.

Inhibition of microtubule polymerization by 3-bromopropionylamino benzoylurea (JIMB01), a new cancericidal tubulin ligand.

Li JN, Song DQ, Lin YH, Hu QY, Yin L, Bekesi G, Holland JF, Jiang JD.

Biochem Pharmacol. 2003 May 15;65(10):1691-9.

PMID:
12754105
46.

Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.

Weiss RB, Woolf SH, Demakos E, Holland JF, Berry DA, Falkson G, Cirrincione CT, Robbins A, Bothun S, Henderson IC, Norton L; Cancer and Leukemia Group B.

J Clin Oncol. 2003 May 1;21(9):1825-35. Erratum in: J Clin Oncol. 2003 Dec 1;21(23):4469.

PMID:
12721260
47.

Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.

Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L.

J Clin Oncol. 2003 Apr 15;21(8):1431-9. Epub 2003 Feb 13. Erratum in: J Clin Oncol. 2003 Jun 1;21(11):2226.

PMID:
12668651
48.

Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer.

Henderson IC, Berry DA, Demetri GD, Cirrincione CT, Goldstein LJ, Martino S, Ingle JN, Cooper MR, Hayes DF, Tkaczuk KH, Fleming G, Holland JF, Duggan DB, Carpenter JT, Frei E 3rd, Schilsky RL, Wood WC, Muss HB, Norton L.

J Clin Oncol. 2003 Mar 15;21(6):976-83.

PMID:
12637460
49.

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

Ling YH, Liebes L, Jiang JD, Holland JF, Elliott PJ, Adams J, Muggia FM, Perez-Soler R.

Clin Cancer Res. 2003 Mar;9(3):1145-54.

50.

Prolonged single-agent versus combination chemotherapy in indolent follicular lymphomas: a study of the cancer and leukemia group B.

Peterson BA, Petroni GR, Frizzera G, Barcos M, Bloomfield CD, Nissen NI, Hurd DD, Henderson ES, Sartiano GP, Johnson JL, Holland JF, Gottlieb AJ.

J Clin Oncol. 2003 Jan 1;21(1):5-15.

PMID:
12506163

Supplemental Content

Loading ...
Support Center